Diabetes

>

Latest News

Tirzepatide Lowers A1C and BMI in Children and Adolescents with Type 2 Diabetes /image credit Riley Children's Health
Tirzepatide Lowers A1C and BMI in Children and Adolescents with Type 2 Diabetes

September 18th 2025

In children aged 10 to <18 with T2D inadequately controlled on standard of care treatment, tirzepatide reduced HbA1c by an average of 2.2% and reduced BMI as well.

Smoking Linked to Increased Risk of All Subtypes of Type 2 Diabetes / image credit Karolinska Institutet
Smoking Linked to Increased Risk of All Subtypes of Type 2 Diabetes

September 16th 2025

FDA Approves Automated Insulin Delivery System for Adults With T2D: Daily Dose / image credit: ©New Africa/AdobeStock
FDA Approves Automated Insulin Delivery System for Adults With T2D: Daily Dose

September 16th 2025

Approximately Half of People with Diabetes Worldwide Do Not Know They Have the Disease
Approximately Half of People with Diabetes Worldwide Do Not Know They Have the Disease: GBD Analysis

September 10th 2025

More Than One-Third of Middle-Aged Adults with Diabetes Prescribed GLP-1 RAs: Daily Dose / image credit: ©New Africa/AdobeStock
More Than One-Third of Middle-Aged Adults with Diabetes Prescribed GLP-1 RAs: Daily Dose

September 1st 2025

More News

© 2025 MJH Life Sciences

All rights reserved.